SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 5,512.45 |
| Enterprise Value ($M) | 5,156.77 |
| Book Value ($M) | -13.91 |
| Book Value / Share | -0.12 |
| Price / Book | -396.27 |
| NCAV ($M) | -431.37 |
| NCAV / Share | -3.66 |
| Price / NCAV | -12.78 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.74 |
| Return on Assets (ROA) | -0.70 |
| Return on Equity (ROE) | n/a |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 9.28 |
| Current Ratio | 9.28 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 1,018.60 |
| Assets | 1,436.06 |
| Liabilities | 1,449.97 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | T. Rowe Price Investment Management, Inc. | 8.20 | ||
| 13G/A | Vanguard Group Inc | 9.99 | 0.00 | |
| 13G/A | BlackRock, Inc. | 13.00 | 0.00 | |
| 13G/A | Fmr Llc | 10.52 | -4.55 | |
| 13G/A | Wellington Management Group Llp | 6.66 | -0.18 | |
| 13G/A | State Street Corp | 6.01 | 16.82 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 230,786 | 1,125,751 | 20.50 | |
| 199,330 | 1,050,508 | 18.97 | |
| 333,053 | 1,492,144 | 22.32 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| CRGX – CARGO Therapeutics, Inc. | CRNX – Crinetics Pharmaceuticals, Inc. |
| CTMX – CytomX Therapeutics, Inc. | DAWN – Day One Biopharmaceuticals, Inc. |
| DNLI – Denali Therapeutics Inc. |
Financial data and stock pages provided by
Fintel.io